维普中文期刊产品整合服务
17篇 您的检索式:作者名="SAPRA H"
    题名 作者 年代 出处 被引量
1Novel delivery of SN38 markedly inhibits tumor growth in xenografts, including a camptothecin-ll-refractory model显示文摘SAPRA P ZHAO H MEHLIG M 2008Clin Cancer Res2008,14,6:1
2Characterizing molecular interactions in different baeteriorhodopsin assemblies by single-molecule force spectroscopy 显示文摘SAPRA K T BESIR H OESTERHELT D 2006J Mol Biol2006,355,4:1
3Marking-to-market: Pana- cea or Pandoras' box显示文摘Plantin G Sapra H Shin H S 2008Journal of Accounting Research2008,40,:1
4Fair value accounting and financial stability显示文摘Plantin G Sapra H Shin H S 2008Financial Stability Review2008,12,:1
5Novel delivery of sn38 markedly inhibits tumor growth in xenografts, including a campto- thecin-11-refractory model显示文摘SAPRA P ZHAO H MEHLIQ M 2008Clin Cancer Res2008,14,6:1
6Novel delivery of SN38 markedly inhibits tumor growth in xenografts, including a campto- thecin-11 -refractory model 显示文摘Sapra P Zhao H Mehlig M 2008Clin Cancer Res2008,14,6:1
7Marking - to - market : Panacea or Pandora' s box? 显示文摘Plantin G Sapra H Shin H S 2008Journal of Accounting Research2008,46,2:1
8Marking-to-Market: Panacea or Pandora' s Box 显示文摘Plantin G Sapra H Shin H S 2008Journal of Accounting Research2008,46,2:1
9Fair Value Accounting and Financial Stability 显示文摘G Plantin H Sapra and H S Shin 2008Banque de France Financial Stability Review2008,,12:1
10Accounting Conservatism and the Efficiency of Debt Contracts显示文摘Gigler F Kanodia C Sapra H 2009Journal of Accounting Research2009,47,3:1
11Novel delivery of SN38 markedly inhibits tumor growth in xenografts, including a camptothecin- 11-refractory model 显示文摘Sapra P Zhao H Mehlig M 2008Clin Cancer Res2008,14,6:1
12Should Intangibles Be measured:What Are the Economic Trade-Offs? 显示文摘Kanodia C Sapra H Venugopalan R 2004Journal of Accounting Research2004,42,1:1
13Marking-to-market:panacea or Pandora's box显示文摘Plantin G Sapra H Shin H.S 0,,46:1
14Novel prodrugs of SN38 using multiarm poly (ethylene glycol) linkers 显示文摘Zhao H Rubio B Sapra P et 1 2008Bioconjug Chem2008,19,4:1
15Marking-to-Market : Panacea or Pandora' s Box? 显示文摘PLANTIN G SAPRA H SHIN H S 2008Journal of Accounting Research2008,46,2:1
16Marking-to-mar- ket:panacea or pandora's box? 显示文摘PLANTIN G SAPRA H SHIN H S 2008Journal of Account- ing Research2008,46,2:1
17Novel delivery of SN38markedly inhibits tumor growth in xenografts,including a camptothecin-11 refractory model显示文摘Sapra P Zhao H Mehlig M 2008Clin Cancer Res2008,14,6:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费